Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embolization, Therapeutic | 2 | 2023 | 225 | 0.800 |
Why?
|
| Arterio-Arterial Fistula | 1 | 2022 | 9 | 0.760 |
Why?
|
| Arteriovenous Fistula | 1 | 2022 | 55 | 0.720 |
Why?
|
| Nasal Cavity | 2 | 2015 | 52 | 0.470 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2025 | 95 | 0.430 |
Why?
|
| Thyroid Diseases | 1 | 2014 | 32 | 0.430 |
Why?
|
| Nasal Obstruction | 1 | 2011 | 15 | 0.360 |
Why?
|
| Stents | 3 | 2025 | 881 | 0.350 |
Why?
|
| Radiology | 3 | 2016 | 127 | 0.290 |
Why?
|
| Renal Dialysis | 2 | 2025 | 893 | 0.280 |
Why?
|
| Kidney Failure, Chronic | 2 | 2025 | 906 | 0.270 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2025 | 793 | 0.260 |
Why?
|
| Endovascular Procedures | 2 | 2025 | 783 | 0.260 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2025 | 21 | 0.230 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2025 | 19 | 0.230 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2025 | 544 | 0.230 |
Why?
|
| Ureteral Obstruction | 1 | 2025 | 105 | 0.210 |
Why?
|
| Fatty Liver | 1 | 2025 | 215 | 0.210 |
Why?
|
| Aneurysm, False | 1 | 2023 | 94 | 0.180 |
Why?
|
| Constriction, Pathologic | 3 | 2025 | 238 | 0.170 |
Why?
|
| Diagnostic Imaging | 2 | 2014 | 317 | 0.160 |
Why?
|
| Pulmonary Artery | 1 | 2022 | 466 | 0.140 |
Why?
|
| Computer-Assisted Instruction | 1 | 2016 | 54 | 0.120 |
Why?
|
| Pituitary Diseases | 1 | 2015 | 14 | 0.120 |
Why?
|
| Radiation Protection | 1 | 2015 | 57 | 0.110 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2025 | 93 | 0.110 |
Why?
|
| Early Diagnosis | 2 | 2015 | 199 | 0.110 |
Why?
|
| Radiography, Interventional | 1 | 2015 | 88 | 0.110 |
Why?
|
| Vascular Patency | 2 | 2025 | 198 | 0.110 |
Why?
|
| Radiation Exposure | 1 | 2015 | 49 | 0.110 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2016 | 158 | 0.110 |
Why?
|
| Safety Management | 1 | 2015 | 121 | 0.110 |
Why?
|
| Occupational Exposure | 1 | 2015 | 131 | 0.110 |
Why?
|
| Treatment Outcome | 6 | 2025 | 13103 | 0.110 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2016 | 202 | 0.100 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2014 | 121 | 0.100 |
Why?
|
| Prosthesis Design | 2 | 2025 | 663 | 0.090 |
Why?
|
| Pyriform Sinus | 1 | 2011 | 8 | 0.090 |
Why?
|
| Sampling Studies | 1 | 2011 | 78 | 0.090 |
Why?
|
| Physics | 1 | 2011 | 8 | 0.090 |
Why?
|
| Humans | 13 | 2025 | 133373 | 0.090 |
Why?
|
| Curriculum | 2 | 2016 | 768 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2011 | 332 | 0.070 |
Why?
|
| Algorithms | 1 | 2014 | 1730 | 0.060 |
Why?
|
| Liver | 2 | 2025 | 1860 | 0.060 |
Why?
|
| Chile | 1 | 2025 | 27 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2011 | 568 | 0.060 |
Why?
|
| Observer Variation | 1 | 2025 | 309 | 0.060 |
Why?
|
| Ureter | 1 | 2025 | 100 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2205 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 3105 | 0.050 |
Why?
|
| Thrombin | 1 | 2023 | 62 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17568 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2015 | 8632 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5443 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2011 | 3718 | 0.050 |
Why?
|
| Survival Rate | 2 | 2025 | 2207 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1513 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2025 | 999 | 0.040 |
Why?
|
| Risk Factors | 2 | 2025 | 10954 | 0.040 |
Why?
|
| Adult | 4 | 2025 | 31684 | 0.040 |
Why?
|
| Infant | 2 | 2015 | 13243 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2015 | 14873 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2025 | 3043 | 0.040 |
Why?
|
| Aged | 3 | 2025 | 21500 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 1998 | 536 | 0.030 |
Why?
|
| Middle Aged | 3 | 2025 | 28985 | 0.030 |
Why?
|
| Time Factors | 1 | 2025 | 6544 | 0.030 |
Why?
|
| Perception | 1 | 2016 | 238 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 460 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 1998 | 737 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 7141 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 708 | 0.020 |
Why?
|
| Female | 4 | 2025 | 71503 | 0.020 |
Why?
|
| Male | 4 | 2025 | 65592 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2016 | 1469 | 0.020 |
Why?
|
| Students, Medical | 1 | 2016 | 363 | 0.020 |
Why?
|
| Melanoma | 1 | 1998 | 963 | 0.020 |
Why?
|
| Young Adult | 1 | 2023 | 9923 | 0.020 |
Why?
|
| Texas | 1 | 2015 | 3666 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2011 | 1253 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 1998 | 60 | 0.010 |
Why?
|
| Injections | 1 | 1998 | 156 | 0.010 |
Why?
|
| Retroviridae | 1 | 1998 | 198 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1998 | 245 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1998 | 399 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 362 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 1097 | 0.010 |
Why?
|
| United States | 1 | 2011 | 11722 | 0.010 |
Why?
|
| Adolescent | 1 | 1998 | 20573 | 0.000 |
Why?
|